Hers vs HealthRx: Wegovy brand vs Compounded GLP-1 Plans
Hers vs HealthRx comparison: Hers emphasizes FDA-approved brand-name Wegovy starting at $149/mo with a required membership, while HealthRx offers compounded semaglutide plans starting at $99/mo on a 12-month prepaid plan. Quick verdict: choose Hers for brand-name, non-compounded Wegovy and a personalized care team; choose HealthRx for lower advertised monthly price and compounded medication options.
Key difference 1: FDA-approved brand-name medication vs compounded options
Hers offers FDA-approved Wegovy, described as brand-name semaglutide and explicitly noted as not compounded. HealthRx offers compounded semaglutide or tirzepatide prepared per prescription and notes that compounded medications are not FDA-approved. The comparison is therefore direct: Hers lists name-brand Wegovy as an FDA-approved, non-compounded option; HealthRx presents a compounded alternative prepared in a licensed 503A pharmacy cleanroom and states compounded medication is not FDA-approved.
Key difference 2: Pricing structure and membership or prepaid requirements
Hers lists Wegovy from $149/mo and indicates an active Hers Weight Loss Membership is required, with a first-month $39 fee and auto-renew at $149/mo thereafter, and that medication is not available without an active membership. HealthRx lists a lower starting monthly price: $99/mo on a 12-month prepaid semaglutide plan ($1,163 today; $1,188 at renewal) and notes the lowest advertised monthly price requires a longer prepaid plan. Both providers state total cost, eligibility and state availability should be confirmed before enrollment.
Key difference 3: Care model and dose management
Hers highlights a personalized care team with ongoing dose check-ins and states treatment is available only when a licensed clinician determines it is medically appropriate. HealthRx explains a clinician reviews your file to decide whether semaglutide or tirzepatide is the right fit and notes dose adjustments are supported and that plan price does not change when dose changes. Both emphasize clinician review and medical eligibility.
Key difference 4: Shipping and fulfillment
HealthRx specifies overnight cold shipping, cold chain tracked and free on every plan. Hers does not publish the same shipping details in the captured evidence. Both require a prescription and note state coverage and availability may vary.
Comparison table
| Criteria | Hers | HealthRx |
|---|---|---|
| Starting price | $149/mo (Wegovy pill from $149/mo; injectable from $199/mo) | $99/mo on a 12-month prepaid semaglutide plan ($1,163 today) |
| Medication type | FDA-approved Wegovy, not compounded | Compounded semaglutide or tirzepatide prepared per prescription |
| Regulatory note | Uses FDA-approved brand-name medication; no compounded medications | Compounded medication is not FDA-approved |
| Membership/prepay | Membership required; first month $39 then auto-renews at $149/mo | Lowest price requires 12-month prepaid plan; renewal terms apply |
| Shipping | Not specified in captured evidence | Overnight cold shipping; cold chain tracked |
| Care model | Personalized care team with ongoing dose check-ins | Clinician review decides medication and supports dose adjustments |
Both providers caution that treatment is available only when a licensed clinician determines it is medically appropriate, and both say eligibility, total cost, renewal terms and state availability should be confirmed before enrollment.
How regulatory and pricing differences affect choice
If having an FDA-approved, brand-name option is essential, Hers explicitly offers Wegovy as a non-compounded, FDA-approved product and emphasizes no compounded medications. If lower advertised monthly price and compounded fulfillment are priorities, HealthRx advertises $99/mo on a 12-month prepaid semaglutide plan and describes compounded options prepared per prescription. HealthRx also highlights free overnight cold shipping and that the plan price does not change with dose increases.
Compare HealthRx shipping and plans
Bottom line and recommendation: Hers vs HealthRx
Hers vs HealthRx boils down to brand-name FDA approval and a personalized care team at Hers versus lower prepaid pricing and compounded preparation at HealthRx. Hers offers FDA-approved Wegovy from $149/mo with membership requirements and ongoing dose check-ins. HealthRx offers compounded semaglutide from $99/mo on a 12-month prepaid plan with overnight cold shipping. Verify eligibility, costs, renewal terms and state availability with either provider.
Choose Hers if…
You want FDA-approved Wegovy, a brand-name semaglutide option that Hers lists as not compounded, plus a personalized care team and dose check-ins, and you accept the membership requirement.
Choose HealthRx if…
You prioritize a lower advertised monthly price on a 12-month prepaid plan and are comfortable with compounded semaglutide or tirzepatide prepared per prescription and shipped with a cold chain.